Oxidized Regenerated Cellulose Can Reduce Hidden Blood Loss after Total Hip Arthroplasty: A Retrospective Study

被引:11
作者
Wang, Ji-Qi [1 ]
Chen, Lu-Ying [2 ]
Jiang, Bing-Jie [1 ]
Zhao, You-Ming [1 ]
机构
[1] Wenzhou Med Univ, Dept Orthopaed, Affiliated Hosp 2, Xue Yuan Xi Rd,109 Xue Yuan Xi Rd, Wenzhou 325000, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Dept Otolaryngol, Affiliated Hosp 1, South White Elephant, Wenzhou, Zhejiang, Peoples R China
关键词
oxidized regenerated cellulose; total hip arthroplasty; hidden blood loss; hemostasis; INTRAVENOUS TRANEXAMIC ACID; TOPICAL HEMOSTATIC AGENTS; TOTAL KNEE ARTHROPLASTY; MANAGEMENT; EFFICACY; RECOMMENDATIONS; TRANSFUSION; STRATEGIES; RISK;
D O I
10.1080/08941939.2018.1458166
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: There is a large amount of hidden blood loss (HBL) after total hip arthroplasty (THA), but the effective and safe methods to reduce HBL are still controversial. Methods: Sixty-nine consecutive patients who underwent THA in our hospital from January 2015 to December 2015 were analyzed retrospectively. The patients were divided into two groups, Group A (THA without oxidized regenerated cellulose) and Group B (THA with oxidized regenerated cellulose). Demographics, perioperative laboratory values, intraoperative data, blood loss, transfusion rate, transfusion reactions, and surgical complications were collected and analyzed. Results: A total of 37 (54%) patients used oxidized regenerated cellulose (ORC) in operation. The total blood loss (TBL), postoperative blood loss (PBL), hemoglobin (Hb) loss, and hidden blood loss (HBL) in group B were significantly lower than in group A. Conclusions: The use of ORC to fill the bone surface and soft tissue gap before incision closure can effectively reduce HBL and may be a potential treatment for blood prevention after THA.
引用
收藏
页码:716 / 722
页数:7
相关论文
共 40 条
  • [1] A Comprehensive Review of Topical Hemostatic Agents Efficacy and Recommendations for Use
    Achneck, Hardean E.
    Sileshi, Bantayehu
    Jamiolkowski, Ryan M.
    Albala, David M.
    Shapiro, Mark L.
    Lawson, Jeffrey H.
    [J]. ANNALS OF SURGERY, 2010, 251 (02) : 217 - 228
  • [2] Brodbelt AR, 2002, ANN ROY COLL SURG, V84, P97
  • [3] Processing, characterization and hemostatic mechanism of a ultraporous collagen/ORC biodegradable composite with excellent biological effectiveness
    Cheng, Weilu
    Li, Hui
    Zheng, Xiongfei
    Chen, Lei
    Cheng, Feng
    He, Jinmei
    Liu, Ke
    Cai, Panpan
    Wang, Xiaofeng
    Huang, Yudong
    [J]. PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2016, 18 (42) : 29183 - 29191
  • [4] Christodoulou A, 2007, ACTA ORTHOP BELG, V73, P778
  • [5] Topical hemostatic agents in surgical practice
    Emilia, Masci
    Luca, Santoleri
    Francesca, Belloni
    Luca, Bottero
    Paolo, Stefanini
    Giuseppe, Faillace
    Gianbattista, Bertani
    Carmela, Montinaro
    Luigi, Mancini
    Mauro, Longoni
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2011, 45 (03) : 305 - 311
  • [6] Fibrin glue-oxidized cellulose sandwich for laparoscopic wedge resection of small renal lesions
    Finley, DS
    Lee, DI
    Eichel, L
    Uribe, CA
    McDougall, EM
    Clayman, RV
    [J]. JOURNAL OF UROLOGY, 2005, 173 (05) : 1477 - 1481
  • [7] An Essential Primer for Understanding the Role of Topical Hemostats, Surgical Sealants, and Adhesives for Maintaining Hemostasis
    Gabay, Michael
    Boucher, Bradley A.
    [J]. PHARMACOTHERAPY, 2013, 33 (09): : 935 - 955
  • [8] ESTIMATING ALLOWABLE BLOOD-LOSS - CORRECTED FOR DILUTION
    GROSS, JB
    [J]. ANESTHESIOLOGY, 1983, 58 (03) : 277 - 280
  • [9] Hart A, 2014, J BONE JOINT SURG AM, V96A, P1945, DOI [10.2106/JBJS.N.00077, 10.2106/JBJS.N.0077]
  • [10] Intraarticular Fibrinogen Does Not Reduce Blood Loss in TKA: A Randomized Clinical Trial
    Heyse, Thomas Jan
    Haas, Steven B.
    Drinkwater, Denise
    Lyman, Stephen
    Kim, Han Jo
    Kahn, Barbara A.
    Figgie, Mark P.
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2014, 472 (01) : 272 - 276